<?xml version="1.0" encoding="UTF-8"?>
<ref id="tbed13734-bib-0011">
 <mixed-citation publication-type="journal" id="tbed13734-cit-0011">
  <string-name>
   <surname>Carbajo‐Lozoya</surname>, 
   <given-names>J.</given-names>
  </string-name>, 
  <string-name>
   <surname>Ma‐Lauer</surname>, 
   <given-names>Y.</given-names>
  </string-name>, 
  <string-name>
   <surname>Malešević</surname>, 
   <given-names>M.</given-names>
  </string-name>, 
  <string-name>
   <surname>Theuerkorn</surname>, 
   <given-names>M.</given-names>
  </string-name>, 
  <string-name>
   <surname>Kahlert</surname>, 
   <given-names>V.</given-names>
  </string-name>, 
  <string-name>
   <surname>Prell</surname>, 
   <given-names>E.</given-names>
  </string-name>, … 
  <string-name>
   <surname>von Brunn</surname>, 
   <given-names>A.</given-names>
  </string-name> (
  <year>2014</year>). 
  <article-title>Human coronavirus NL63 replication is cyclophilin A‐dependent and inhibited by non‐immunosuppressive cyclosporine A‐derivatives including Alisporivir</article-title>. 
  <source xml:lang="en">Virus Research</source>, 
  <volume>184</volume>, 
  <fpage>44</fpage>–
  <lpage>53</lpage>. 
  <pub-id pub-id-type="doi">10.1016/j.virusres.2014.02.010</pub-id>
  <pub-id pub-id-type="pmid">24566223</pub-id>
 </mixed-citation>
</ref>
